See also:
Source: Newfoundland and Labrador Department of Health and Community Services
Drugs that are covered:
http://www.health.gov.nl.ca/health/prescription/newformulary.asp
NLPDP info:
http://www.health.gov.nl.ca/health/prescription/index.html
NLPDP Forms:
http://www.health.gov.nl.ca/health/forms/index.html#4
Standard Special Authorization Form
Notable special auth:
- Ozempic (semaglutide) a once-weekly GLP1 covered after metformin and sulfonylurea
Notable open benefits:
- Plavix (Clopidogrel)
- Basaglar (Insulin glargine)
- Tresiba (Insulin degludec) ultra-long acting insulin
- Enstilar (calcipotriol/betamethasone dipropionate) spray foam AAA daily disp 60 g (indicated for psoriasis vulgaris)
- Ritalin-SR (methylphenidate SR) is covered (20 mg tablets)
- Concerta (methylphenidate ER) is not covered unless failed trial of SR
Special auth criteria PDFs:
- Advair (Fluticasone/Salmeterol)
- Aricept (Donepezil)
- Breo Ellipta (Fluticasone/Vilanterol)
- Eliquis (Apixaban)
- Femara (Letrozole)
- Januvia (Sitagliptin)
- Lovenox (Enoxaparin)
- Lyrica (Pregabalin)
- Neurontin (Gabapentin)
- Prolia (Denosumab)
- Singulair (Montelukast)
- Spiriva (Tiotropium)
- Symbicort (Budesonide/Formoterol)
- Ventolin nebules (Salbutamol)
- Xarelto (Rivaroxaban)
- Zenhale (Mometasone/Formoterol)
Content on this page has not been checked for accuracy. The author's credentials have not been confirmed. Always use multiple peer-reviewed scholarly sources and good clinical judgement in your decision making.
The Compendium platform was created by David Kwinter, MD, CCFP(EM).